1. Department of Health and Human Services (DHHS) 2018. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available at: https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Accessed 25 March 2019.
2. Tenofovir alafenamide: anovel prodrug of tenofovir for the treatment of human immunodeficiency virus;AS Ray;Antivir Res,2015
3. A Comprehensive Development Agenda on Tenofovir Alafenamide in Clinical Practice.;A Di Biagio;AIDS Rev,2018
4. Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M).;S Di Giambenedetto;J Antimicrob Chemother,2017
5. Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides;A Di Biagio;Int J Antimicrob Agents,2016